autologous dendritic cell vaccine (IRVICS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous dendritic cell vaccine (IRVICS)

Drug Alias Nameautologous dendritic cell vaccine (Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancer et du Sida)autologous dendritic cell vaccine (Institute of Research on Vaccines and Immunotherapy of Cancers and AIDS)

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFranceBrazil

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Research On Vaccines And Immunotherapy Of Cancer And Aids

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Research On Vaccines And Immunotherapy Of Cancer And Aids

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A